The Save Sight Registries aim to analyse patient-centred outcomes of all the different ways eye diseases are treated around the world in order to identify which works best and how it can be used to get the best results for everybody.READ MORE
Investigates the safety and effectiveness of available and new drugs as they “hit the market” for retinal diseases, including macular degeneration, diabetic retinopathy and retinal vein occlusion. We are developing strategies which will reduce the incidence of retinal blindness.READ MORE
Graphs of long-term patient centred treatment outcomes such as vision on an eye chart and how it responds to different treatments over time can be generated at the push of a button by clinicians and shown to patients.READ MORE
Save Sight Registries are clinician managed web-based data collection tools that track and analyse the outcomes of treatments for eye diseases, delivering benefits to patients, doctors, governments and other stakeholders. Our reports provide a robust framework for public health programs, health interventions and health research. The Save Sight Registries were established in 2007 under the directorship of Professor Mark Gillies
The Fight Retinal Blindness! registry was launched to the Australian and international communities in 2010, the Fight Corneal Blindness! registry in 2015, the Fight Glaucoma Blindness! in 2017 and most recently the Fight Tumour Blindness! registry in late 2018.
Our current international partners include Switzerland, The Netherlands, Belgium, France, New Zealand, Spain, Singapore and the United Kingdom.
Save Sight Registries are endorsed by the International Consortium for Health Outcomes Measurement (ICHOM) as a preferred tool for the collection of the minimum data set for macular degeneration.